FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Bard Recalls BD 4 Fr. PowerPICC Catheters

[ Price : $8.95]

Bard Access Systems recalls its BD 4 Fr. Single Lumen PowerPICC Catheters due to tubing that exceeded melt flow index specificatio...

QApel Recalls Aspitration System

[ Price : $8.95]

QApel Medical recalls and discontinues the marketing of its 072 Aspiration System (also known under the product name Hippo and Che...

Rare Disease Drug Development Articles

[ Price : $8.95]

Researchers publish two journal articles relating to rare disease drug development.

AI in Regulatory Science: Conference Report

[ Price : $8.95]

A report on the 2024 Global Summit on Regulatory Science calls for a collaborative global effort to harness artificial intelligenc...

Digital Health Technologies an FDA Priority: Article

[ Price : $8.95]

Three FDA staffers discuss the agencys efforts to advance the use of digital health technologies in clinical trials.

Inspections Will Suffer Under FDA Cuts: Lawyers

[ Price : $8.95]

Recent FDA layoffs raise concerns across the drug and biologic industries as experts warn that diminished inspection capacity coul...

Hill Staffer Graham Appointed to FDA Policy Office

[ Price : $8.95]

FDA appoints Capitol Hill staffer Grace Graham as deputy commissioner for policy, legislation, and international affairs.

FDA Wants Contractors to Replace Some Fired Staff

[ Price : $8.95]

FDA is recruiting contractors to do the travel logistics work for inspections and investigations that was done by staff who have b...

2 Medical Device FAQs Issued

[ Price : $8.95]

FDA issues two documents answering frequently asked questions about reporting medical device recalls, corrections, and adverse eve...

Celltrions Humira Biosimilar Now Interchangeable: FDA

[ Price : $8.95]

FDA grants interchangeable biosimilar status to Celltrions Yuflyma (adalimumab-aaty), a biosimilar copy of AbbVies Humira.